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Abstract
In a previous study we proposed that the depolarized state of the wake-promoting hypocretin/orexin (hcrt/orx) neurons
was independent of synaptic inputs as it persisted in tetrodotoxin and low calcium/high magnesium solutions. Here we
show first that these cells are hyperpolarized when external sodium is lowered, suggesting that non-selective cation
channels (NSCCs) could be involved. As canonical transient receptor channels (TRPCs) are known to form NSCCs, we looked
for TRPCs subunits using single-cell RT-PCR and found that TRPC6 mRNA was detectable in a small minority, TRPC1, TRPC3
and TRPC7 in a majority and TRPC4 and 5 in the vast majority (,90%) of hcrt/orx neurons. Using intracellular applications of
TRPC antibodies against subunits known to form NSCCs, we then found that only TRPC5 antibodies elicited an outward
current, together with hyperpolarization and inhibition of the cells. These effects were blocked by co-application of a TRPC5
antigen peptide. Voltage-clamp ramps in the presence or absence of TRPC5 antibodies indicated the presence of a current
with a reversal potential close to 215 mV. Application of the non-selective TRPC channel blocker, flufenamic acid, had a
similar effect, which could be occluded in cells pre-loaded with TRPC5 antibodies. Finally, using the same TRPC5 antibodies
we found that most hcrt/orx cells show immunostaining for the TRPC5 subunit. These results suggest that hcrt/orx neurons
are endowed with a constitutively active non-selective cation current which depends on TRPC channels containing the
TRPC5 subunit and which is responsible for the depolarized and active state of these cells.
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Introduction
The hypothalamic hypocretin/orexin (hcrt/orx) neurons are
critical for maintaining a waking state (for reviews, see [1–4]).
Giving rise to widespread projections throughout the brain [5],
they play a central role in promoting waking through the
excitatory actions of their peptide upon multiple arousal systems
[6–10]. During the natural sleep-wake cycle, they discharge during
waking and in association with behavioral arousal [11,12].
In a previous study [13], we showed in vitro that hcrt/orx
neurons were spontaneously active and maintained in a depolar-
ized state. We then demonstrated that this state did not depend
upon voltage-dependent sodium channels or synaptic activity as it
was not modified in the presence of tetrodotoxin (TTX) and/or a
low Ca
2+/high Mg
2+ solution. Evidence that cesium also did not
affect the depolarized state indicated that an Ih current was not
implicated either. Although the mechanism underlying the
depolarized state could not be established at that time, we
speculated that it could be due to the presence of a non-selective
cation current.
Several channels have been shown to carry non-selective cation
currents (see for review [14]) and could thus be candidates to
conduct the current that maintains hcrt/orx cells in their
depolarized state. Among them, are the seven members of the
‘‘canonical’’ transient receptor potential (TRPC) subfamily [15],
which belongs to a wider superfamily of cation-permeable TRP
channels [16,17]. The role of TRPC channels in maintaining a
depolarized state in neurons was recently demonstrated in
GABAergic neurons of the substantia nigra pars reticulata (SNr)
where TRPC3 channels were implicated [18].
In the present study, we thus hypothesized that the depolarized
state of hcrt/orx neurons might also depend upon the presence of
constitutively active TRPC channels. Our results, while indicating
that this is indeed the case, differ from those in the SNr [18]. In
hcrt/orx neurons, TRPC channels containing the TRPC5 subunit
are involved and these channels have properties which are quite
different from those in the SNr.
Results
The depolarized state of hcrt/orx neurons is due to a
non-selective cation current
Hcrt/orx neurons were identified by the usual criteria [13]. In
short, a depolarizing step applied at rest yielded tonic firing
(Fig. 1A), whereas in condition of membrane hyperpolarization, it
yielded a depolarizing response characterized by the successive
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plateau potential (arrows in Fig. 1B). Such neurons were
previously identified by immunohistochemistry as expressing
hcrt/orx [13].
In a preceding in vitro study [13], all hcrt/orx neurons were
found to be in a depolarized state which was affected by neither
low calcium, nor TTX, nor cesium (to block the Ih current). We
can add here that while nickel (100 mM, n=3) had no effect on the
resting potential, the calcium channel blocker cadmium (0.5 to
1.0 mM; in 0.1 mM calcium) slightly hyperpolarized the cells
(mean DV 6 SEM =23.761.0 mV, n=5; not shown). We then
hypothesized that the depolarized state could be due to the
presence of a non-selective cation current having sodium as a
major charge carrier [18]. We therefore tested whether lowering
sodium in the bath from 150 to 20 mM, by substituting sodium
chloride with choline chloride, would affect the membrane
potential. As shown in Fig. 1C, neurons immediately hyperpolar-
ized (mean 6 SEM =211.5560.53 mV, n=4) in this condition.
Subtracting voltage-clamp ramps obtained in control (ACSF) with
ramps obtained after sodium substitution (Fig. 1D) then allowed us
to characterize the current underlying the depolarized state (inset
of Fig. 1D). As illustrated below (with respect to the effect of a
TRPC antibody or flufenamic acid, FFA), this current exhibits a
strong voltage-dependence with a region of negative slope and
shows a reversal potential around 25 mV (mean 6 SEM =
26.160.95 mV, n=3) compatible with it being a non-selective
cation current.
Finally it should be noted that although removing calcium from
the ACSF did not affect the membrane potential and blocking
voltage-dependent calcium channels only had a minimal effect, a
basic level of intracellular calcium was needed to maintain the
depolarized state. Indeed, intracellular application of BAPTA
(20 mM instead of 0.1 mM) strongly hyperpolarized the cells
(mean DV 6 SEM =215.361.4 mV, n=7). Altogether these
results suggest the presence of NSCCs in hrct/orx neurons.
TRPC subunits expressed in hcrt/orx neurons
Since NSCCs can be composed of TRPC subunits (see
Discussion) and given the recent evidence of substantia nigra
neurons being maintained in an intrinsic depolarized state by
TRPC channels [18], we investigated the possible involvement
of TRPCs in the depolarized state of hcrt/orx neurons. For that
purpose, we studied first whether these neurons express TRPC
subunits using single-cell multiplex RT-PCR. The RT-PCR
conditions were determined using 100 to 500 pg of total RNAs
purified from hypothalamic slices. In these conditions, six
TRPC subunits (i.e. TRPC1 and TRPC3-7; TRPC2 not being
reported for reasons exposed in the Methods) along with hcrt/
orx transcripts were successfully detected, each generating a
PCR fragment of the size predicted by its mRNA sequence
(Fig. 2A). The identity of the fragments was confirmed by
sequencing.
Single-cell RT-PCR was then used to investigate the expression
of TRPC subunits in 41 hcrt/orx cells, which were identified by
their electrophysiological properties. Hcrt/orx cDNA was success-
fully amplified in all neurons and, depending on the TRPC
subunit present, a number of different expression patterns were
identified. The main pattern was characterized by the presence of
TRPC1, 3, 4, 5 and 7 (illustrated on Fig. 2B) and was found in 12
(out of 41) hcrt/orx neurons (* in Fig. 2C), whereas other patterns
(Fig. 2C) were found less frequently, some of them being present in
only one cell. Taken together, as illustrated in Fig. 2D, only
TRPC4 and 5 were present in almost every cell (37/41) and were
thus considered as the prime candidates for a role in the tonic
depolarization characterizing all hcrt/orx neurons.
Figure 1. Hyperpolarization of hcrt/orx neurons by substitution of sodium with choline chloride. (A–B) Tonic firing in presence of a
depolarizing step (A) and a low-threshold spike (dot) followed by plateau potential (double arrow) when the depolarizing step is given under DC
hyperpolarization (B) is characteristic of hcrt/orx neurons. (C) Substitution of sodium chloride with choline chloride in the bath produces a
hyperpolarization and cessation of firing. (D) Voltage-clamp ramps in control (Ctrl) conditions and after choline substitution. The subtraction of ramps
shown in the inset suggests the presence of a voltage-dependent cationic current.
doi:10.1371/journal.pone.0015673.g001
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antibody
Because we found a majority of hcrt/orx neurons expressing the
TRPC4 and 5 subunits, we investigated their function by using
intracellular applications of specific antibodies (6 ng/ml) against
TRPC4 and 5 subunits. With the same approach, we also
examined the potential involvement of the TRPC3 subunit (found
in 23 of 41 cells), since it was shown to be involved in the tonic
depolarization of SNr GABAergic neurons [18], and the TRPC1
subunit (found in 30 of 41 cells), since it can co-assemble with a
TRPC5 subunit to form a functional hetero-multimere channel
[19].
Intracellular application of TRPC1,3 or 4 antibodies on
voltage-clamped cells, yielded no change in the current needed
to maintain them at 250 mV (TRPC1, Fig. 3A, mean DI 6 SEM =
20.7662 . 7 8 p A ,n = 5 ;T R P C 3 ,F i g .3 B ,m e a nDI= 1 . 7 8 6
1 . 6 7 p A ,n = 8 ;T R P C 4 ,F i g .3 C ,m e a nDI= 22.6061.91 pA,
n=6).
In contrast, application of the TRPC5 antibody (Fig. 3D)
produced a persistent outward current (mean DI 6 SEM =
77.0615.2 pA, n=9). This response was specific as it could be
blocked (Fig. 3E) by co-application of a TRPC5 antigen (used at
12 or 18 ng/ml) with the TRPC5 antibody (mean DI=
21.3861.38 pA, n=4). In current-clamp, the TRPC5 antibody
hyperpolarized (Fig. 3F) and completely inhibited the cells (mean
DV 6 SEM =211.1660.73 mV, n=10) together with an
elimination of the plateau potential (n=3/3, not shown). The
hyperpolarizing action was antagonized (Fig. 3G; mean DV=
20.3360.20 mV, n=4) by co-application of the antibody with
the corresponding antigen. The hyperpolarizing action of the
TRPC5 antibody (from Alomone Labs) was checked with an
antibody from a different source (NeuroMab, used in [20] also
applied intracellularly at 6 ng/ml which yielded similar results
(inset of Fig. 3F, mean DV 6 SEM =212.0861.56 mV, n=4;
Student’s t test Alomone versus NeuroMab p=0.62).
Finally it should be stressed that in 3/3 non-hcrt/orx neurons
(according to their electrophysiological properties) held at
250 mV, application of the TRPC5 antibody yielded no change
of membrane current (not shown).
Hcrt/orx neurons are depolarized by active TRPC
channels
The above data suggest that a non-selective cation current,
depending on the presence of channels containing the TRPC5
subunit, could maintain the neurons in their depolarized state. To
further substantiate this view, we studied first hcrt/orx cells with
voltage-clamp ramps in presence of TTX. As illustrated in Fig. 3H
(inset), subtraction of a control ramp obtained immediately after
whole-cell is established with one obtained a few minutes later, as
the TRPC5 antibody diffuses into the cell, indicates the presence
of a current with a strong voltage-dependence and a region of
negative slope. Its reversal potential close to 215 mV (mean 6
SEM =217.4360.52 mV, n=3) is compatible with it being a
non-selective cation current. At rest, which in hcrt/orx cells is
close to 245 mV [13], this current must thus contribute to their
depolarized state and spontaneous activity. The fact that this
current is active at rest might explain why lanthanum (100 mM),
which is known as a positive modulator of TRPC5 channels [19],
had no effect here (n=3/3).
To further substantiate the suggestion that TRPCs are
involved in maintaining the depolarized state of hcrt/orx
neurons, we tested the effect of the non-selective TRPC blocker,
flufenamic acid (FFA). As illustrated in Fig. 4A, application of
FFA (100 mM), induced a hyperpolarization (mean DV 6 SEM =
211.8860.72 mV, n=4) or an outward current (inset of Fig. 4A;
mean DI 6 SEM =152.562.5 pA, n=3). Using voltage-clamp
Figure 2. Single-cell RT-PCR of TRPCs in hcrt/orx neurons. (A) RT-PCR experiment on 500 pg total RNAs isolated from the hypothalamus.
Agarose gel electrophoresis showing that mRNAs encoding the TRPC1, 3, 4, 5, 6, and 7 are all detected and generate PCR fragments with sizes of
respectively 363, 333, 402, 129, 114 and 337 bp. The hcrt/orx PCR fragment size is 189 bp. MW: molecular weight (100 bp DNA ladder). (B) Single-cell
RT-PCR experiment. Agarose gel electrophoresis illustrating the more frequently observed TRPC expression pattern, found in 12 out of 41 hcrt/orx
cells. It corresponds to TRPC1, 3, 4, 5 and 7. MW: molecular weight (100 bp DNA ladder). (C) Different TRPC expression patterns identified in the 41
hcrt/orx cells investigated. The asterisk indicates the more frequently observed pattern also illustrated in panel B. (D) Histogram showing the
occurrence of the different TRPC subunits in the 41 investigated cells.
doi:10.1371/journal.pone.0015673.g002
TRPC5-DEPENDENT DEPOLARIZATION OF HCRT/ORX NEURONS TRPC5-Dependent Depolarization of Hcrt/orx Neurons
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15673ramps, it can be seen (inset of Fig. 4B) that the subtracted current
has a shape similar to the one observed with sodium chloride
substitution or the TRPC5 antibody. The mean reversal potential
was also in the same range (mean Einv (FFA) 6 SEM =
210.4362.31 mV, n=3). To determine whether the TRPC5
antibody and FFA share the same target, we applied FFA in cells
that were pre-loaded with the antibody. As shown in Fig. 4C,
following the usual hyperpolarization by the antibody, applica-
tion of FFA had only a small hyperpolarizing effect left (mean DV
6 SEM =23.2960.08 mV, n=4) that is a 70.3% reduction of
the FFA effect (Student’s t test comparing the effect of FFA in
absence versus presence of TRPC5 antibody in the pipette;
p=0.001). Similar results were obtained in voltage-clamp, in
presence of TTX, where again FFA applied in cells pre-loaded
with the antibody, showed only a minimal effect (mean DI 6
SEM =23.562.85 mV, n=3) that is a 84.6% reduction of the
FFA effect (Student’s t test comparing the effect of FFA in
absence versus presence of TRPC5 antibody in the pipette
p,0.001).
The TRPC-dependent current observed here could depend on
the presence of transmitters, released tonically by neurons in the
slice in a calcium-independent manner [21]. As transmitters are
thought to activate TRPC channels [16,22] via an increase in
phospholipase C (PLC), as illustrated notably in the action of
glutamate [23] and acetylcholine [19,24], we tested this hypothesis
using long-lasting (at least 20 min) perfusion with U-73122, a PLC
inhibitor, but found that cells never hyperpolarized with this
treatment (n=3, not shown).
Immunohistochemical demonstration of TRPC5 subunits
in hcrt/orx neurons
The TRPC5 subunit expression in hcrt/orx cells was verified by
dual immunohistochemical staining combining immunoperoxi-
dase staining for TRPC5 and immunofluorescence staining for
hcrt/orx. Immunostaining for hcrt/orx with the two antibodies
employed revealed cytoplasmic staining of multiple neurons
through the perifornical hypothalamus (Fig. 5A,C), as previously
described [25]. With the two antibodies employed for TRPC5
(from Alomone Labs and NeuroMab), peroxidase staining of the
cytoplasm of multiple cells was evident through the perifornical
hypothalamus (Fig. 5B,D). The TRPC5 labelling was observed in
many hcrt/orx-positive cells (arrowheads in Fig. 5A–D and double
circles magnified in images on the right) and also hcrt/orx-
negative cells (examples indicated by downward going arrows in
Fig. 5A–D) of varying sizes. As illustrated in Fig. 5A–D (single
circle) some hcrt/orx cells did not show TRPC5 staining with
either antibody. We found 78.7% (with Alomone labs) and 70.6%
(with NeuroMab TRPC5 antibodies) of hcrt/orx cells to be
immunopositive for TRPC5.
Figure 3. The depolarized state of hcrt/orx neurons is blocked by a TRPC5 antibody. (A–C) In voltage-clamp configuration, intracellular
application of either a TRPC1 (A) or a TRPC3 (B) or a TRPC4 (C) antibody (AbTRPC1, AbTRPC3 and AbTRPC4 respectively, all from Alomone Labs) has
no effect on the current needed to clamp the cell at 250 mV. (D–E) Intracellular application of a TRPC5 antibody (Alomone Labs), in contrast, induces
an outward current (D) that is blocked by co-application of a TRPC5 antigen (E). (F–G) In current-clamp configuration, intracellular application of a
TRPC5 antibody alone (from either Alomone Labs (F) or NeuroMab (inset in F) induces an important membrane hyperpolarization and cessation of
firing. In contrast, intracellular co-application of the TRPC5 antibody (Alomone Labs) together with its appropriate antigen (AgTRPC5) has no effect (G,
to compare with F). (H) Voltage-clamp ramps in absence (Ctrl) and presence of a TRPC5 antibody (AbTRPC5, Alomone Labs). In the inset, subtraction
of voltage-clamp ramps (Ctrl - AbTRPC5) suggests the presence of a voltage-dependent TRPC5 current.
doi:10.1371/journal.pone.0015673.g003
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acid (FFA), a non specific blocker of cationic currents, produces a strong membrane hyperpolarization and cessation of firing; inset: in voltage-clamp
this hyperpolarization corresponds to an outward current. (B) Voltage-clamp ramps in absence (Ctrl) and presence (FFA) of flufenamic acid. The
subtraction of voltage-clamp ramps shown in the inset suggests the presence of a voltage-dependent cationic current. (C–D) In hcrt/orx neurons
loaded with a TRPC5 antibody, bath-application of FFA had only a small additional effect either in current-clamp (C) or in voltage-clamp (D).
doi:10.1371/journal.pone.0015673.g004
Figure 5. Dual immunohistochemical staining for TRPC5 and hcrt/orx. (A–B) Photomicrographs from a dual-immunostained section
combining an hcrt/orx antibody from Santa Cruz (A) and a TRPC5 antibody from Alomone Labs (B). Examples of double labelled hcrt/orx-TRPC5 cells
are indicated by white arrowheads and one such cell by a double circle (enlarged in the corresponding small panels to the right). Some hcrt/orx cells
do not express TRPC5, as shown by an example indicated with a single circle. It is noteworthy that many hcrt/orx-negative cells also expressed TRPC5,
as shown by an example indicated with a downward arrow (in panels A and B). (C–D) Same as in A and B with an hcrt/orx antibody from Phoenix
Pharmaceuticals (C) and a TRPC5 antibody from NeuroMab (D). (Scale bars: 20 mm).
doi:10.1371/journal.pone.0015673.g005
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From our previous in vitro work in which we discovered that
hcrt/orx neurons are in a depolarized and active state indepen-
dent of synaptic inputs [13], we postulated that this state could be
due to the presence of NSCCs. Here, we provide evidence that the
membrane depolarization and spontaneous activity are main-
tained by a non-selective cation current depending on the presence
of TRPC channels containing TRPC5 subunits.
That the depolarized state of hcrt/orx neurons depends on the
presence of a non-selective cation current is based on several
arguments. First, we previously demonstrated [13] that the
depolarized state could not depend on voltage-dependent sodium
channels or synaptic inputs since it persisted in presence of TTX
and/or a low Ca
2+/high Mg
2+ solution. Further evidence that the
depolarized state does not depend critically on voltage-dependent
calcium channels was reported here since nickel had no effect and
cadmium only a minimal one. The depolarized state depended
however on a basal level of intracellular calcium since loading cells
with BAPTA led to a strong membrane hyperpolarization as we
report here. Second, we previously found [13] that the depolarized
state could not depend on the Ih current since cesium would not
lead to membrane hyperpolarization either. Third, in the present
study, we found in contrast that substituting sodium chloride with
choline chloride immediately led to a hyperpolarization (or
outward current in voltage-clamp) of the cells. Fourth, the reversal
potential of the tonic current removed by the sodium substitution
was around 25 mV, which fits with a non-selective cation current.
That the non-selective current was dependent on TRPC
channels relies on several arguments. First, we show here that
the hcrt/orx neurons can be hyperpolarized (or show an outward
current) in presence of flufenamic acid, a blocker of TRPC
channels (for reviews [14,16]). The reversal potential of the current
removed by FFA was similar to the one removed by sodium
substitution. Although FFA is not specific for TRPCs, as it
interferes with a number of other channels [14], it provides
preliminary evidence of a role for TRPCs. Second, the single-cell
RT-PCR investigation demonstrated that mRNAs for many
TRPC subunits are present in hcrt/orx cells and that for at least
two of them, TRPC4 and 5, they are present in the vast majority
(,90%) of the cells. Third, by using specific antibodies against the
intracellular part of different TRPC subunits, as recently used in
mammalian neurons of the amygdala [23] and substantia nigra
[18], we could show that TRPC5 subunits are implicated in the
depolarized state of hcrt/orx cells. Indeed, application of a
TRPC5 antibody induced a hyperpolarization (or outward
current) similar to that seen with FFA or sodium chloride
substitution, including a similar reversal potential. The effect of
the TRPC5 antibody was specific as it was blocked when the
TRPC5 antigen peptide was co-applied. Fourth, the effect of FFA
could be occluded by pre-loading of the cells with the antibody,
indicating that both experiments involve the same target. Finally,
immunohistochemical staining performed with the same TRPC5
antibodies which were used in the physiological experiments
showed that the TRPC5 subunits are present in 70 to 80% of
hcrt/orx cells.
The TRPC channels are part of a 7-member subfamily of non-
selective cation channels [15], which is itself part of the TRP
superfamily that comprises six families of cation-permeable
channels [16,17]. Depending on the TRPC subtype and the tissue
involved, TRPC channels were shown to be activated by a variety
of stimuli (including neurotransmitters) or to be constitutively
active. More specifically and relevant to our study, constitutively
active TRPC3 channels have recently been shown to be
responsible for the depolarized and active state of GABAergic
neurons in the SNr [18], following the earlier demonstration of
TRPC3 channels playing a similar role in rabbit ear arterial
myocytes [26]. Our results in hcrt/orx neurons also suggest the
presence of constitutively active TRPC channels, given the
hyperpolarizing action of sodium chloride substitution, FFA, and
a TRPC antibody, coupled to the lack of effect of blocking
synaptic transmission or impeding phospholipase C dependent
pathways [22]. Our results however differ from those in SNr
neurons as TRPC5 subunits are implicated here and, in addition,
the current described in the present study has a strong voltage-
dependence, not very different from the one seen in HEK cells co-
transfected with TRPC1 and TRPC5 cDNAs [19]. In our study,
application of a TRPC1 antibody was however ineffective, leaving
the possibility open that a heteromultimer of TRPC5 and TRPC1
subunits is at play here. Others [23] had encountered similar
difficulties, not being able to reduce metabotropic responses to
glutamate with a TRPC1 antibody alone (while a TRPC5
antibody worked) and yet having a voltage-dependence of the
current typical for the TRPC1/TRPC5 heteromultimer. Of final
notice, the voltage-dependence of the current in hcrt/orx neurons
and its sensitivity to intracellular calcium could explain the
presence of the plateau potential and its boosting by the low-
threshold calcium spike [13].
Functionally, these results support the hypothesis that the
natural state of hcrt/orx neurons is depolarized and spontaneously
active. This intrinsic property is likely important for the role of
hcrt/orx neurons in promoting and maintaining wakefulness
since their excitatory influence upon the multiple arousal systems
[5–10] could be maintained without exogenous input. Their
decreased activity during sleep [11,12] should thus mainly depend
upon the GABAergic inhibitory input they receive from sleep-
promoting neurons located in the preoptic area and basal
forebrain [13,27–30].
In conclusion, our results indicate that hcrt/orx neurons are
endowed with a non-selective cation current carried by TRPC
channels, which are constitutively open at the resting potential of
these cells, and thereby contribute to their depolarized and active
state.
Methods
Slice preparation and electrophysiological recordings
Hypothalamic coronal brain slices (250 mm thick) containing
the hcrt/orx neurons were obtained from young Sprague-Dawley
rats (18–21 days) reared at the animal facility of the Geneva
Medical Center or obtained from Charles-River Laboratories
(France) and treated according to the rules of the Swiss Federal
Veterinary Office. The study was reviewed and approved by the
‘‘office ve ´te ´rinaire cantonal’’ (approval ID: 31.1.1007/3248/
0). Before use, slices were incubated at room temperature in
artificial cerebrospinal fluid (ACSF) containing in (mM): NaCl
130, KCl 5, KH2PO4 1.25, MgSO4 1.3, NaHCO3 20, glucose 10
and CaCl2 2.4 (bubbled with 95% O2 and 5% CO2). Individual
slices were then transferred to a thermoregulated (32uC) recording
chamber mounted on an upright microscope (Axioskop, Zeiss,
Oberkochen, Germany) equipped with an infrared camera (TILL-
Photonics, Gra ¨felfing, Germany). Slices were maintained im-
mersed and continuously superfused at 4–5 ml/min with ACSF.
Whole-cell recordings were obtained with patch electrodes (3–
5M V) that were pulled on a DMZ universal puller (Zeitz-
Instrumente, Munich, Germany) from borosilicate capillaries
(GC150F-10, Harvard instruments, UK). The pipettes were filled
with a solution containing (in mM): KMeSO4 126, KCl 4, MgCl2
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ATP 3, GTP 0.1, pH 7.3, 285–300 mOsm. High BAPTA
experiments were done with electrodes having the same
composition with the exception of BAPTA raised to 20 mM and
KMeSO4 lowered to 86 mM (the results of BAPTA experiments
were already reported with respect to the effect on the plateau
potentials [13] but not with respect to the influence on resting
potentials, which are thus reported here). Whole-cell recordings
were performed in the current clamp or voltage clamp mode using
an Axopatch 200B amplifier (Axon Instruments, Union City, CA).
The membrane potential values were not compensated for
junction potential (estimated at 29.6 mV). Membrane potentials
were around 245 mV (on a sample of 30 cells, mean 6 SEM
=245.9460.73 mV, n=30), as previously described [13]. It
could be measured easily as firing is irregular in these cells.
Membrane resistance was not systematically checked but on a
random sample of recordings it was around 500 MV (mean 6
SEM =525.23648.96 MV, n=10).
Voltage-clamp experiments were all done in presence of
tetrodotoxin (TTX, 10
26 M, Latoxan, France) with series
resistance (usual range from 10 to 20 MV) monitored continuously
by short-lasting hyperpolarizing steps to 250 mV every 5 seconds
(not visible on the figure traces as voltage/current plots are
sampled outside the steps by the analysis/display software).
Experiments were discarded if series resistance varied more than
20%. In some voltage-clamp experiments, IV relations were
obtained with voltage ramps (duration 500 ms to 6 s; delivered
every 5 to 60 s) from +10, +20 or +50 mV to 290 mV (decreasing
ramps used to inactivate calcium currents).
For experiments using intracellular application of TRPC
antibodies (see below), the pipettes were first tip-filled with a
pipette solution devoid of TRPC antibody and then back-filled
with 3.5 ml of a pipette solution containing the tested TRPC at a
final concentration of 6 ng/ml. When used, the TRPC5 control
antigen (Alomone Labs) was added (at 12 or 18 ng/ml) to the
TRPC5 antibody in the pipette.
Chemicals
Most chemicals were obtained from Sigma-Aldrich (Buchs,
Switzerland), with the exception of the PLC inhibitor, U-73122
from Tocris (Lucernachem, Lucerne, Switzerland). To avoid
precipitation, lanthanum (100 mM) was used in an ACSF
containing in mM: NaCl 150, KCl 6.25, Hepes 11, glucose 10,
MgCl2, 1.3, sucrose 18 and CaCl2 2.4. For experiments with
choline chloride, 130 mM of NaCl were substituted with 130 mM
of choline chloride in the ACSF.
When testing TRPCs antibodies, those for TRPC1, 3 and 4
were obtained from Alomone Labs (Jerusalem, Israel), whereas the
one for TRPC5 was obtained from either Alomone Labs or
NeuroMab (UC Davis, California, USA). References and
validation (based on physiology, western blotting, immunohisto-
chemistry, antisense and siRNA approaches) for the Alomone
antibodies used in the present study (i.e. for TRPC1, 3, 4 and 5)
can be found in the following papers: for TRPC1 [31–36]; for
TRPC3 [18,26,35,37,38]; for TRPC4 [34–36,39]; for TRPC5
[31,35,39–41]. For validation of the TRPC5 NeuroMab antibody,
see [20].
Single-cell RT-PCR
The multiplex PCR conditions were first optimized using total
RNA purified (RNA Now, Ozyme, Saint-Quentin-en-Yvelines,
France) from hypothalamic slices containing hcrt/orx neurons
(250 mm thick, from a 19 days-old rat), so that all TRPC subunits
and hcrt/orx transcripts could be detected from 100 to 500 pg of
total RNA, and were then applied to the single cell studies.
The identities of the amplified fragments were confirmed by
sequencing.
Following electrophysiological identification of the neuron
(Fig. 1A,B see Eggermann et al., 2003), the cell content was
aspirated under visual control into the patch pipette containing
8 ml of intra-pipette solution. The pipette content was immediately
expelled into a tube containing 20 U of RNase inhibitor
(Stratagene, Basel, Switzerland) for blocking RNase activity and
20 U of DNase I (Qiagen, Courtaboeuf, France) for digestion of
genomic DNA. Samples were incubated at 37uC for 30 min,
followed by incubation at 75uC for 5 min to inactivate the DNase.
The different cDNAs were then synthesized overnight at 37uCi na
total reaction volume of about 15 ml containing random hexamer
primers (3.33 mM; Roche Applied Science, Rotkreuz, Switzer-
land), the four deoxyribonucleotide triphosphates (333 mM;
Invitrogen, Lucerne, Switzerland), dithiothreitol (6.6 mM; Sigma,
Buchs, Switzerland), RNase inhibitor (20 U, Stratagene), and
reverse transcriptase (Superscript II; 200 U; Invitrogen). The
cDNAs for the different TRPC subunits and for hcrt/orx were first
simultaneously amplified in a multiplex PCR reaction using
degenerate (Dg) primers [42,43] for TRPC subunits and the
following primers (from 59 to 39) for hcrt/orx (189 bp): sense TGC
CGT CTC TAC GAA CTG TTG CAC G, antisense AGG GAT
ATG GCT CTA GCT CTG CGC C.
Multiplex PCR was performed in a final reaction volume of
50 ml containing the totality of the RT reaction, Herculase
Hotstart DNA polymerase (2.5 U; Stratagene), deoxyribonucleo-
tide triphosphates (0.2 mM each; Invitrogen), 1 mM of each Dg
primers and 50 nM of each hcrt/orx primers with the following
cycling protocol: after 5 min at 94uC, 35 cycles (94uC for 48 s,
50uC for 1 min, 72uC for 90 s) were run followed by a final
elongation period of 10 min at 72uC. In a second round of PCR,
each TRPC subunit and hcrt/orx cDNAs were specifically
amplified (using 1 mM of each TRPC nested primers and
0.1 mM of each hcrt/orx primers) in individual reactions with
2 ml of the multiplex PCR product under similar conditions for 35
cycles (94uC for 30 s, 52uC for 45 s, 72uC for 2 min). The PCR
products (15 ml) were analyzed in ethidium bromide-stained
agarose gels (2%).
The primers used for TRPC1 (363 bp), TRPC5 (129 bp) and
TRPC6 (114 bp) amplifications were from [44]. For TRPC3
(333 bp), TRPC4 (402 bp) and TRPC7 (337 bp), the following
primers were used (from 59 to 39): TRPC3 sense GAC TGT CGA
AGA CAT ATT CCA GTT CA, antisense ACA TCA CTG TCA
TCC TCG ATT TCT T; TRPC4 sense [44], antisense GCA
AAT TTC CAC TCT ATA TCT GCG TG; TRPC7 sense GAA
CTG TGA AAG ACA TCT TCA AGT T, antisense TCC ACG
TCT GCG TCT TCC TCG ATT.
Although TRPC2 expression is restricted to the vomeronasal
organ [45] and could have been skipped, we attempted to analyze
it in the present study but were unsuccessful. In a preliminary
study on total rat hypothalamic RNAs, using two different TRPC2
couples of primers [42,44] and different RT-PCR protocols, we
could not get a clean amplification of a product with the expected
length. The bands obtained were sequenced but did not
correspond to TRPC2. It is noteworthy that similar problems
were encountered by others [23].
Finally, to validate our results, several controls were done: 1) to
check for non-specific harvesting of surrounding tissue compo-
nents, pipettes containing 8 ml of the internal solution were
advanced into slices and retrieved without sealing and aspirating
before proceeding to RT-PCR protocol. 2) For each PCR
amplification, controls for contaminating artifacts were performed
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harvesting the content of a hcrt/orx neuron and processing it
while omitting the RT was also performed. As expected, all types
of controls gave negative results.
GenBank accession numbers
Hcrt/orx (NM_013179), TRPC1 (NM_053558), TRPC3
(AB022331), TRPC4 (NM_001083115, NM_080396), TRPC5
(NM_080898), TRPC6 (NM_053559), TRPC7 (XM_225159,
XM_001067646).
Double immunohistochemistry for hcrt/orx and TRPC5
Paraformaldehyde-fixed brains from 18-19 days-old rats were
serially cut into 30-mm coronal floating sections on a cryostat. A
protocol combining immunoperoxidase staining for TRPC5
(adapted from NeuroMab (http://www.neuromab.org/Perox_
secs.pdf)) and immunofluorescence staining for hcrt/orx was
performed. Sections were first processed for the TRPC5
immunoperoxidase staining using two different antibodies (one
from Alomone Labs, rabbit polyclonal, dilution 1:100 and the
other from NeuroMab, mouse monoclonal, clone N67/15,
dilution 1:50). Sections were subsequently immersed for 30 min.
in 0.3% H2O2 in PBS at RT, rinsed in TBS (0.15M NaCl, 50 mM
Tris, pH 7.5), 45 min. in 0.5% Triton X-100 in TBS at 4uC,
rinsed in TBS, 45 min. in TBS containing 0.1% Triton X-100 and
5% normal serum (from the same species as the secondary
antibody, donkey or horse serum) at 4uC and then incubated for
48 h at 4uC in the TRPC5 antibody. Following rinsing in TBS,
sections were incubated two hours at 4uC in a secondary
biotinylated donkey anti-rabbit IgG (Jackson ImmunoResearch,
USA, dilution 1:200) or biotinylated horse anti-mouse IgG
antibody (Vector Laboratories, USA, dilution 1:200) and pro-
cessed according to the avidin-biotin complex (ABC) method
(Vectastain Elite ABC Kit, Vector Laboratories, USA). The
sections were developed for peroxidase reactivity with 3,39-
diaminobenzidine (DAB, Sigma-Aldrich, USA) from 5 to 10
minutes until desired stain intensity was obtained. The hcrt/orx
staining was secondly revealed using a goat orexin-A antibody
(Santa Cruz Biotechnology, Germany, dilution 1:500) when the
rabbit TRPC5 antibody was used or the rabbit orexin-A antibody
(Phoenix Pharmaceuticals, Germany, dilution 1:1000) when the
mouse TRPC5 antibody was used. Sections were incubated
30 min in TBS containing 0.1% Triton X-100 and 5% normal
donkey serum, then overnight with the orexin antibody at RT,
followed by two hours incubation with Alexa-Fluor 488-conjugat-
ed donkey anti-goat or anti-rabbit IgG secondary antibody
(Invitrogen, Switzerland, dilution 1:500).
Primary and secondary antibodies were all diluted in a TBS
solution containing 0.1% Triton X-100 and 5% normal serum (for
TRPC5 step) or 3% normal serum (for hcrt/orx step) (the normal
serum was from the same species as the secondary antibody used
in each step). Sections were observed with a Zeiss Axioskop 2
microscope equipped with an AxioCam color CCD camera
(Zeiss). Images were recorded on a computer through the
AxioVision software (Zeiss).
To ensure specificity of the immunohistochemical staining,
different control conditions were tested. Sections were incubated
without the TRPC5 or the hcrt/orx primary antibody and
processed for dual-immunostaining. In these series, no staining
was evident for TRPC5 or hcrt/orx in the respective series lacking
the primary antibody. Other sections were incubated with the
rabbit anti-TRPC5 antibody (Alomone Labs) that had been
preincubated with the corresponding control antigen (from
Alomone Labs, in a ratio of 1:3 for 2 hours at room temperature).
(The control antigen for the TRPC5 antibody from NeuroMab
was not available.) In these sections, the immunostaining for
TRPC5 was eliminated by the pre-adsorption of the primary
antibody with the antigen.
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